Chris Moreau
Chief Executive Officer at ALGERNON PHARMACEUTICALS INC.
Net worth: 125 178 $ as of 2024-05-30
Profile
Christopher Joseph Moreau is currently the Chief Executive Officer & Director at Algernon Pharmaceuticals, Inc. He previously held positions as the President, CEO, Director & Head-Investor Relations at Luminor Medical Technologies, Inc. from 2011 to 2015.
He also served as the Chief Executive Officer at Nash Pharmaceuticals, Inc. Additionally, he was a Director at First Responder Technologies, Inc. from 2019 to 2020.
He has also held the position of President at Advansis Capital Corp.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-06-19 | 1,088,502 ( 5.44% ) | 125 178 $ | 2024-05-30 |
Chris Moreau active positions
| Companies | Position | Start |
|---|---|---|
| ALGERNON PHARMACEUTICALS INC. | Chief Executive Officer | 2018-02-28 |
Former positions of Chris Moreau
| Companies | Position | End |
|---|---|---|
| QUEBEC HOLDINGS PEGMATITE | President | 2019-07-23 |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Chief Executive Officer | 2016-04-20 |
Nash Pharmaceuticals, Inc.
 Nash Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nash Pharmaceuticals, Inc. engages in the research and development of repurposed therapeutic drugs and pharmaceutical products. Its focus areas include non-alcoholic steatohepatitis, chronic kidney disease, and inflammatory bowel disease. The company is headquartered in Vancouver, Canada. | Chief Executive Officer | - |
| Advansis Capital Corp. | President | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ALGERNON PHARMACEUTICALS INC. | Health Technology |
| Private companies | 4 |
|---|---|
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Commercial Services |
| Advansis Capital Corp. | |
Nash Pharmaceuticals, Inc.
Nash Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nash Pharmaceuticals, Inc. engages in the research and development of repurposed therapeutic drugs and pharmaceutical products. Its focus areas include non-alcoholic steatohepatitis, chronic kidney disease, and inflammatory bowel disease. The company is headquartered in Vancouver, Canada. | Health Technology |
First Responder Technologies, Inc.
 First Responder Technologies, Inc. Aerospace & DefenseElectronic Technology First Responder Technologies, Inc. is in the process of exploring business opportunities. The company was founded on January 27, 2017 and is headquartered in Vancouver, Canada. | Electronic Technology |
- Stock Market
- Insiders
- Chris Moreau
